Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis

Author:

Selvarajah Brintha1ORCID,Azuelos Ilan1ORCID,Anastasiou Dimitrios2ORCID,Chambers Rachel C.1ORCID

Affiliation:

1. Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London WC1E 6JF, UK.

2. Cancer Metabolism Laboratory, The Francis Crick Institute, London NW1 1AT, UK.

Abstract

Metabolic reprogramming of myofibroblasts promotes fibrosis and could be targeted to treat fibrotic diseases.

Funder

GlaxoSmithKline

Wellcome

Medical Research Council

Medical Research Council Canada

Mauritius Research Council

Biotechnology and Biological Research Council

NIHR University College London Hospitals Biomedical Research Centre

Fonds de la Recherche en Sante-Quebec

Medical Reseach Council UK

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3